Selected research
Market Structure
Global GMP Lentivirus Production Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global GMP Lentivirus Production Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for GMP Lentivirus Production Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for GMP Lentivirus Production Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for GMP Lentivirus Production Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for GMP Lentivirus Production Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of GMP Lentivirus Production Service include AGC Biologics, Biocompare, BPS Bioscience, Charles River Laboratories, Creative Biogene, Hillgene Biopharma, OXB, ProBio CDMO and ProBioGen AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global GMP Lentivirus Production Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of GMP Lentivirus Production Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents GMP Lentivirus Production Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the GMP Lentivirus Production Service market size, projected growth trends, production technologies, key applications, and end-use industries.
GMP Lentivirus Production Service Segment by Company
AGC Biologics
Biocompare
BPS Bioscience
Charles River Laboratories
Creative Biogene
Hillgene Biopharma
OXB
ProBio CDMO
ProBioGen AG
Revvity
SK pharmteco
Thermo Fisher Scientific
VectorBuilder
VIVEbiotech
GMP Lentivirus Production Service Segment by Type
R&D and Preclinical Service
Early Clinical (Phase I/II) Service
Late Clinical and Commercial (Phase III/Launch) Service
GMP Lentivirus Production Service Segment by Application
CAR-T Therapy
Vaccine Development
Gene Editing
Others
GMP Lentivirus Production Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GMP Lentivirus Production Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of GMP Lentivirus Production Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GMP Lentivirus Production Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of GMP Lentivirus Production Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global GMP Lentivirus Production Service industry.
Chapter 3: Detailed analysis of GMP Lentivirus Production Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, GMP Lentivirus Production Servicerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- R&D and Preclinical Service
- Early Clinical (Phase I/II) Service
- Late Clinical and Commercial (Phase III/Launch) Service
Applications
- CAR-T Therapy
- Vaccine Development
- Gene Editing
- Others
Companies covered
- AGC Biologics
- Biocompare
- BPS Bioscience
- Charles River Laboratories
- Creative Biogene
- Hillgene Biopharma
- OXB
- ProBio CDMO
- ProBioGen AG
- Revvity
- SK pharmteco
- Thermo Fisher Scientific
- VectorBuilder
- VIVEbiotech
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global GMP Lentivirus Production Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 R&D and Preclinical Service
- 1.2.3 Early Clinical (Phase I/II) Service
- 1.2.4 Late Clinical and Commercial (Phase III/Launch) Service
- 1.3 Market Analysis by Application
- 1.3.1 Global GMP Lentivirus Production Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 CAR-T Therapy
- 1.3.3 Vaccine Development
- 1.3.4 Gene Editing
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global GMP Lentivirus Production Service Growth Trends by Region
- 1.5.1 Global GMP Lentivirus Production Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 GMP Lentivirus Production Service Market Size by Region (2021-2026)
- 1.5.3 GMP Lentivirus Production Service Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global GMP Lentivirus Production Service Market Dynamics
- 2.1 GMP Lentivirus Production Service Industry Trends
- 2.2 GMP Lentivirus Production Service Industry Drivers
- 2.3 GMP Lentivirus Production Service Industry Opportunities and Challenges
- 2.4 GMP Lentivirus Production Service Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global GMP Lentivirus Production Service Revenue by Company (2021-2026)
- 3.2 Global GMP Lentivirus Production Service Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global GMP Lentivirus Production Service Key Company Head office and Area Served
- 3.4 Global GMP Lentivirus Production Service Company, Product Type & Application
- 3.5 Global GMP Lentivirus Production Service Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global GMP Lentivirus Production Service Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 GMP Lentivirus Production Service Players Market Share by Revenue in 2025
- 3.6.3 2025 GMP Lentivirus Production Service Tier 1, Tier 2, and Tier 3
4 GMP Lentivirus Production Service Market by Type
- 4.1 Global GMP Lentivirus Production Service Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global GMP Lentivirus Production Service Market Size by Type (2021-2032)
- 4.3 Global GMP Lentivirus Production Service Market Size Share by Type (2021-2032)
5 GMP Lentivirus Production Service Market by Application
- 5.1 Global GMP Lentivirus Production Service Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global GMP Lentivirus Production Service Market Size by Application (2021-2032)
- 5.3 Global GMP Lentivirus Production Service Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 AGC Biologics
- 6.1.1 AGC Biologics Company Information
- 6.1.2 AGC Biologics Business Overview
- 6.1.3 AGC Biologics GMP Lentivirus Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 AGC Biologics GMP Lentivirus Production Service Product Portfolio
- 6.1.5 AGC Biologics Recent Developments
- 6.2 Biocompare
- 6.2.1 Biocompare Company Information
- 6.2.2 Biocompare Business Overview
- 6.2.3 Biocompare GMP Lentivirus Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Biocompare GMP Lentivirus Production Service Product Portfolio
- 6.2.5 Biocompare Recent Developments
- 6.3 BPS Bioscience
- 6.3.1 BPS Bioscience Company Information
- 6.3.2 BPS Bioscience Business Overview
- 6.3.3 BPS Bioscience GMP Lentivirus Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 BPS Bioscience GMP Lentivirus Production Service Product Portfolio
- 6.3.5 BPS Bioscience Recent Developments
- 6.4 Charles River Laboratories
- 6.4.1 Charles River Laboratories Company Information
- 6.4.2 Charles River Laboratories Business Overview
- 6.4.3 Charles River Laboratories GMP Lentivirus Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Charles River Laboratories GMP Lentivirus Production Service Product Portfolio
- 6.4.5 Charles River Laboratories Recent Developments
- 6.5 Creative Biogene
- 6.5.1 Creative Biogene Company Information
- 6.5.2 Creative Biogene Business Overview
- 6.5.3 Creative Biogene GMP Lentivirus Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Creative Biogene GMP Lentivirus Production Service Product Portfolio
- 6.5.5 Creative Biogene Recent Developments
- 6.6 Hillgene Biopharma
- 6.6.1 Hillgene Biopharma Company Information
- 6.6.2 Hillgene Biopharma Business Overview
- 6.6.3 Hillgene Biopharma GMP Lentivirus Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Hillgene Biopharma GMP Lentivirus Production Service Product Portfolio
- 6.6.5 Hillgene Biopharma Recent Developments
- 6.7 OXB
- 6.7.1 OXB Company Information
- 6.7.2 OXB Business Overview
- 6.7.3 OXB GMP Lentivirus Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 OXB GMP Lentivirus Production Service Product Portfolio
- 6.7.5 OXB Recent Developments
- 6.8 ProBio CDMO
- 6.8.1 ProBio CDMO Company Information
- 6.8.2 ProBio CDMO Business Overview
- 6.8.3 ProBio CDMO GMP Lentivirus Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 ProBio CDMO GMP Lentivirus Production Service Product Portfolio
- 6.8.5 ProBio CDMO Recent Developments
- 6.9 ProBioGen AG
- 6.9.1 ProBioGen AG Company Information
- 6.9.2 ProBioGen AG Business Overview
- 6.9.3 ProBioGen AG GMP Lentivirus Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 ProBioGen AG GMP Lentivirus Production Service Product Portfolio
- 6.9.5 ProBioGen AG Recent Developments
- 6.10 Revvity
- 6.10.1 Revvity Company Information
- 6.10.2 Revvity Business Overview
- 6.10.3 Revvity GMP Lentivirus Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Revvity GMP Lentivirus Production Service Product Portfolio
- 6.10.5 Revvity Recent Developments
- 6.11 SK pharmteco
- 6.11.1 SK pharmteco Company Information
- 6.11.2 SK pharmteco Business Overview
- 6.11.3 SK pharmteco GMP Lentivirus Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 SK pharmteco GMP Lentivirus Production Service Product Portfolio
- 6.11.5 SK pharmteco Recent Developments
- 6.12 Thermo Fisher Scientific
- 6.12.1 Thermo Fisher Scientific Company Information
- 6.12.2 Thermo Fisher Scientific Business Overview
- 6.12.3 Thermo Fisher Scientific GMP Lentivirus Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Thermo Fisher Scientific GMP Lentivirus Production Service Product Portfolio
- 6.12.5 Thermo Fisher Scientific Recent Developments
- 6.13 VectorBuilder
- 6.13.1 VectorBuilder Company Information
- 6.13.2 VectorBuilder Business Overview
- 6.13.3 VectorBuilder GMP Lentivirus Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 VectorBuilder GMP Lentivirus Production Service Product Portfolio
- 6.13.5 VectorBuilder Recent Developments
- 6.14 VIVEbiotech
- 6.14.1 VIVEbiotech Company Information
- 6.14.2 VIVEbiotech Business Overview
- 6.14.3 VIVEbiotech GMP Lentivirus Production Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 VIVEbiotech GMP Lentivirus Production Service Product Portfolio
- 6.14.5 VIVEbiotech Recent Developments
7 North America
- 7.1 North America GMP Lentivirus Production Service Market Size (2021-2032)
- 7.2 North America GMP Lentivirus Production Service Market Size by Type
- 7.2.1 North America GMP Lentivirus Production Service Market Size by Type (2021-2026)
- 7.2.2 North America GMP Lentivirus Production Service Market Size by Type (2027-2032)
- 7.2.3 North America GMP Lentivirus Production Service Market Share by Type (2021-2032)
- 7.3 North America GMP Lentivirus Production Service Market Size by Application
- 7.3.1 North America GMP Lentivirus Production Service Market Size by Application (2021-2026)
- 7.3.2 North America GMP Lentivirus Production Service Market Size by Application (2027-2032)
- 7.3.3 North America GMP Lentivirus Production Service Market Share by Application (2021-2032)
- 7.4 North America GMP Lentivirus Production Service Market Size by Country
- 7.4.1 North America GMP Lentivirus Production Service Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America GMP Lentivirus Production Service Market Size by Country (2021-2026)
- 7.4.3 North America GMP Lentivirus Production Service Market Size by Country (2027-2032)
- 7.4.4 North America GMP Lentivirus Production Service Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe GMP Lentivirus Production Service Market Size (2021-2032)
- 8.2 Europe GMP Lentivirus Production Service Market Size by Type
- 8.2.1 Europe GMP Lentivirus Production Service Market Size by Type (2021-2026)
- 8.2.2 Europe GMP Lentivirus Production Service Market Size by Type (2027-2032)
- 8.2.3 Europe GMP Lentivirus Production Service Market Share by Type (2021-2032)
- 8.3 Europe GMP Lentivirus Production Service Market Size by Application
- 8.3.1 Europe GMP Lentivirus Production Service Market Size by Application (2021-2026)
- 8.3.2 Europe GMP Lentivirus Production Service Market Size by Application (2027-2032)
- 8.3.3 Europe GMP Lentivirus Production Service Market Share by Application (2021-2032)
- 8.4 Europe GMP Lentivirus Production Service Market Size by Country
- 8.4.1 Europe GMP Lentivirus Production Service Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe GMP Lentivirus Production Service Market Size by Country (2021-2026)
- 8.4.3 Europe GMP Lentivirus Production Service Market Size by Country (2027-2032)
- 8.4.4 Europe GMP Lentivirus Production Service Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China GMP Lentivirus Production Service Market Size (2021-2032)
- 9.2 China GMP Lentivirus Production Service Market Size by Type
- 9.2.1 China GMP Lentivirus Production Service Market Size by Type (2021-2026)
- 9.2.2 China GMP Lentivirus Production Service Market Size by Type (2027-2032)
- 9.2.3 China GMP Lentivirus Production Service Market Share by Type (2021-2032)
- 9.3 China GMP Lentivirus Production Service Market Size by Application
- 9.3.1 China GMP Lentivirus Production Service Market Size by Application (2021-2026)
- 9.3.2 China GMP Lentivirus Production Service Market Size by Application (2027-2032)
- 9.3.3 China GMP Lentivirus Production Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia GMP Lentivirus Production Service Market Size (2021-2032)
- 10.2 Asia GMP Lentivirus Production Service Market Size by Type
- 10.2.1 Asia GMP Lentivirus Production Service Market Size by Type (2021-2026)
- 10.2.2 Asia GMP Lentivirus Production Service Market Size by Type (2027-2032)
- 10.2.3 Asia GMP Lentivirus Production Service Market Share by Type (2021-2032)
- 10.3 Asia GMP Lentivirus Production Service Market Size by Application
- 10.3.1 Asia GMP Lentivirus Production Service Market Size by Application (2021-2026)
- 10.3.2 Asia GMP Lentivirus Production Service Market Size by Application (2027-2032)
- 10.3.3 Asia GMP Lentivirus Production Service Market Share by Application (2021-2032)
- 10.4 Asia GMP Lentivirus Production Service Market Size by Country
- 10.4.1 Asia GMP Lentivirus Production Service Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia GMP Lentivirus Production Service Market Size by Country (2021-2026)
- 10.4.3 Asia GMP Lentivirus Production Service Market Size by Country (2027-2032)
- 10.4.4 Asia GMP Lentivirus Production Service Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa GMP Lentivirus Production Service Market Size (2021-2032)
- 11.2 South America, Middle East & Africa GMP Lentivirus Production Service Market Size by Type
- 11.2.1 South America, Middle East & Africa GMP Lentivirus Production Service Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa GMP Lentivirus Production Service Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa GMP Lentivirus Production Service Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa GMP Lentivirus Production Service Market Size by Application
- 11.3.1 South America, Middle East & Africa GMP Lentivirus Production Service Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa GMP Lentivirus Production Service Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa GMP Lentivirus Production Service Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa GMP Lentivirus Production Service Market Size by Country
- 11.4.1 South America, Middle East & Africa GMP Lentivirus Production Service Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa GMP Lentivirus Production Service Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa GMP Lentivirus Production Service Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa GMP Lentivirus Production Service Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst